Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-Educational Conferences
-Annual Meeting
 Registration Information
 Childcare Program
 Teen Track
 Session Descriptions
 Registration Fee Waivers
 Exhibits
 Educational Participant Grants
 Awards of Distinction and Excellence
 Poster Abstracts
 Annual Meeting Sessions Audio CDs
 Sponsors
 Future Annual Meetings
 Inhibitor Education Summits

 

 

 
Hemophilia Specialty Pharmacy Management Symposium
 
Hemophilia Management and Specialty Pharmacy: Collaborating in a New Era to Optimize Outcomes
Follow us on Twitter Follow us on Twitter

Reserve your spot today for the inaugural National Hemophilia (NHF) Annual Meeting Pre-Conference Symposium on Hemophilia Specialty Pharmacy Management:

Thursday, October 3, 2013
2:30 PM - 5:00 PM
Anaheim Convention Center
Room: 210AB
Anaheim, CA


Please use the link at the bottom of this page to register.

Hemophilia Management and Specialty Pharmacy: Collaborating in a New Era to Optimize Outcomes

Hot Topics Include:
  • Current Practices and Trends in the Treatment of Hemophilia
  • Coordinating Payer Strategies for General Hemophilia and Hemophilia with Inhibitors
  • Applying a Collaborative Approach Among the Key Stakeholders
  • Hemophilia Specialty Pharmacy Management Services: Steps for Success

Held in conjunction with the National Hemophilia Foundation's 65th Annual Meeting, "United in Progress"
NHF's 65th Annual Meeting


1 Free iPad Available

Eligible applicants must:
  • Submit a relevant case study regarding hemophilia management in specialty pharmacy (500-word limit) to info@impactedu.net by September 9, 2013
  • Register and attend the live symposium on October 3, 2013
iPad Recipient:
  • Program faculty will review the case studies submitted and select 1 case study to present and discuss during the symposium
  • The applicant who submitted the selected case study will receive a free iPad at the live symposium

Distinguished Faculty Presenters
Jeff Dunn, PharmD, MBA William D. LaPiana, M.T. (A.S.C.P.)
Regional Director / Advanced Therapies
Accredo, An Express Scripts Co.
Marion Koerper, MD Jennifer Maahs, RN, PNP, MSN
Nurse Practitioner
Indiana Hemophilia and Thrombosis Center
Raulo Frear, PharmD Steven W. Pipe, MD
Director, Division of Pediatric Hematology and Oncology
Pediatric Medical Director, Hemophilia and Coagulation Disorders Program
University of Michigan
William D. LaPiana, M.T. (A.S.C.P.) James Jorgenson, RPh, MS, FASHP
Chief Operating Officer
Visante, Inc.


Who Should Attend?
This activity is designed to meet the educational needs of specialty pharmacists, home health pharmacists, health plan pharmacists, managed Medicaid pharmacists, medical directors, and other health care professionals with an interest in the management of patients with hemophilia.

Statement of Need/Program Overview
Hemophilia is an expensive chronic condition with total annual costs that can average $250,000 or more for severe patients. Optimal outcomes requires a collaborative and coordinated patient experience. The collaborative team can include an insurer, Hemophilia Treatment Center (HTC), and specialty pharmacy. Specialty pharmacy services can support patient adherence to treatment and assist physicians, plans and employers in meeting clinical and/or financial goals. This symposium, joint sponsored by the National Hemophilia Foundation, will emphasize the need for well-coordinated treatment management, the importance of understanding effective ways of using available treatments, and the importance of collaboration among all stakeholders.

Educational Objectives
After completing this activity, the participant should be better able to:
  • Review the pathophysiology of general hemophilia and hemophilia with inhibitors.
  • Describe the impact of hemophilia and hemophilia with inhibitors on clinical, economic, and humanistic outcomes
  • Assess the available hemophilia therapies for both children and adults, with and without inhibitors
  • Implement the Medical and Scientific Advisory Council (MASAC) Quality of Care Guidelines for the treatment of hemophilia
  • Evaluate current and emerging patient management techniques to optimize specialty pharmacy management services
  • Employ collaborative care strategies and resources, including Hemophilia Treatment Centers (HTCs), to improve care coordination for health plan patients with hemophilia
  • Provide accurate and appropriate counsel as part of the treatment team.

Agenda
Thursday, October 3, 2013
2:30 PM - 5:00 PM
Anaheim Marriott
Room TBD
Anaheim, CA
2:00-2:30 pm Registration and Refreshments
2:30-2:35 pm Introduction and Objectives/Opening Comments
William D. LaPiana, M.T. (A.S.C.P.)
2:35-3:05 pm Current Practices and Trends in the Treatment of Hemophilia:
A Primer for Managed Care Professionals

Steven W. Pipe, MD
3:05-3:35 pm Coordinating Payer Strategies for General Hemophilia and Hemophilia with Inhibitors
James Jorgenson, RPh, MS, FASHP
3:35-4:05 pm Applying a Collaborative Approach to Hemophilia Management Among Key Stakeholders
Jennifer Maahs, RN, PNP, MSN
4:05-4:40 pm Hemophilia Specialty Pharmacy Management Services: Steps for Success
William D. LaPiana, M.T. (A.S.C.P.)
4:40-5:00 pm Question and Answer Session
Evaluation and Post-Activity Survey

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine, National Hemophilia Foundation, and Impact Education, LLC. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 2.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Accreditation Statement
ACPE Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 2.5 contact hours (0.25 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0809-9999-13-297-L01-P)

Upon receipt of the completed activity evaluation form, transcript information will be available at www.mycpemonitor.net within 4 weeks.

Type of Activity: Application

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Fee Information
No additional fee is required to attend this CPE/CME activity.

Note: There is NO FEE for attending this Special Pre-Conference Symposium. However, if you wish to attend the NHF Annual Meeting sessions from October 3rd through October 5th, a registration fee is required.

Pre-registration will close at 12:00 pm on October 1, 2013. Walk-in registration will be available at the time of the program.

If you have any questions, please call (215) 619-8812 or email info@impactedu.net.


Click here to register.